Ledger.

Professor, University of Queensland

Mark Kendell

Coverage

Stories naming Mark Kendell. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Unnamed stage $15m

Vaxxas gets $15m injection to develop needle-free vaccine

Biotech startup Vaxxas has raised $15 million in venture capital, led by OneVentures with Brandon Capital, MRCF and HealthCare Ventures, to commercialise the Nanopatch needle-free vaccine delivery technology developed at Queensland university institute AIBN.

labonline.com.au Tue 2 Aug 2011 VaxxasUniversity of QueenslandBrandon CapitalHealthcare VenturesMedical Research Commercialisation Fund (MRCF)OneVenturesMark KendellDr Paul Kelly

Also SmartCompany·labonline.com.au

Something wrong? Tell us